Condition
Hepatitis C, Acute
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 3 (1)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT02634008Phase 3CompletedPrimary
Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P
NCT03459768Unknown
Cohort Study on People Who Inject Drugs in Senegal
NCT03839979CompletedPrimary
HCV Viral Hepatitis, Blood Sugar Level and Systolic Blood Pressure in Egypt
Showing all 3 trials